Craft
  • Home
  •  / ALX Oncology
ALX Oncology

ALX Oncology

Total Funding

$166 M

ALX Oncology Summary

Company summary

Overview
ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment. Its anticancer antibodies help the immune system to eradicate cancer from the system, enabling physicians to enhance the efficacy of antibody-based therapies in clinical development.
Type
Private
Founded
2015
HQ
Burlingame, CA, US | view all locations
Website
http://alxoncology.com
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Jaume Pons

    Jaume Pons, President and Chief Executive Officer, Director

    • Corey Goodman, Executive Chairman

      • Emma Abellana

        Emma Abellana, Senior Director, Finance and Controller

        • Nathan Caffo

          Nathan Caffo, Chief Business Officer

          LocationsView all

          2 locations detected

          • Burlingame, CA HQ

            United States

            866 Malcolm Rd #100

          • Dublin 2, D

            Ireland

            9, 2 Pembroke Street Upper

          Footer menu